Calian Group (TSE:CGY) Price Target Raised to C$80.00

Calian Group (TSE:CGY) had its price target raised by Canaccord Genuity Group from C$63.00 to C$80.00 in a research note published on Friday,BayStreet.CA reports.

CGY has been the subject of a number of other reports. Ventum Financial lifted their price objective on shares of Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a research note on Tuesday, January 27th. Canadian Imperial Bank of Commerce raised their price target on Calian Group from C$65.00 to C$76.00 in a report on Friday. Royal Bank Of Canada boosted their price objective on Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a research note on Thursday, November 27th. Finally, Desjardins increased their price objective on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a report on Thursday, November 27th. Six research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of C$74.83.

Calian Group Price Performance

TSE CGY opened at C$70.60 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company has a market cap of C$805.62 million, a PE ratio of 30.96, a price-to-earnings-growth ratio of 2.50 and a beta of 0.70. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$71.92. The firm’s 50-day simple moving average is C$60.38 and its two-hundred day simple moving average is C$54.15.

Calian Group (TSE:CGY) last posted its earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. The firm had revenue of C$208.00 million during the quarter. Research analysts predict that Calian Group will post 4.9475219 earnings per share for the current year.

Calian Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 11th. Stockholders of record on Wednesday, March 11th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Wednesday, February 25th. This represents a $1.12 annualized dividend and a dividend yield of 1.6%. Calian Group’s dividend payout ratio is presently 49.12%.

Trending Headlines about Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.